Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform that is intended for the chemical modification of protein therapeutics, primarily antibody-drug conjugates. Its proprietary technology targets delivery of anti-cancer drugs to cancerous tumors. The company is headquartered in Boston, Massachusetts.
Advanced Proteome Therapeutics Corporatn CVE:APC
Today's live share price, quote history, chart & news
About Advanced Proteome Therapeutics Corporatn
|Name||Advanced Proteome Therapeutics Corporatn|
|Exchange||TSX Venture Exchange|